Observational studyPloS one2021

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.

Giorgia Montrucchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.